Press Releases
Jan. 16, 2026
Trends in Nonwoven Fabrics Market 2026-35
Indeterminate
GlobeNewswire, Inc.
Jan. 13, 2026
Rutte discusses "next steps" to ensure security in Arctic
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Oct. 22, 2025
Alvotech Announces Changes in Global Business Development and Commercial Operations Team
Indeterminate
GlobeNewswire, Inc.
Sep. 8, 2025
Halli Thorleifsson Relaunches Ueno to Humanize the Future of Tech
Neutral
EIN Presswire
Nov. 14, 2025
Too Lost Expands Global Reach, Inking New Deal With Melon in South Korea
Neutral
EIN Presswire
Dec. 15, 2025
Portuguese Artists Protest Eurovision Over Israel’s Participation
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Dec. 13, 2025
Eurovision Winner Says to Return Trophy Over Israel's Inclusion
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Jan. 12, 2026
VIVUS Shares Progress on Pipeline and Key Program Milestones During the 44th Annual J.P. Morgan Healthcare Conference
Indeterminate
GlobeNewswire, Inc.
Jan. 7, 2026
Rubio says Trump wants to buy Greenland from Denmark
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Dec. 7, 2025
UEFA penalizes Ukraine for displaying anti-Russian
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Jan. 7, 2026
Helvetic Clinics Cements Status as Europe’s Premier Dental Destination with Double-Digit Growth in 2025
Neutral
EIN Presswire
Sep. 22, 2025
European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech’s Proposed Biosimilar to Prolia® and Xgeva®
Indeterminate
GlobeNewswire, Inc.
Sep. 19, 2025
Alvotech Announces Marketing Approval in Japan of Three New Biosimilars
Indeterminate
GlobeNewswire, Inc.
Jan. 5, 2026
Why Respiratory Vaccines Remain a Strategic Focus for Healthcare Systems Worldwide?
Indeterminate
GlobeNewswire, Inc.
Dec. 23, 2025
Animation Market Size USD 953.31 Bn by 2035 Growing Use of Animated Content Across Industries
Indeterminate
GlobeNewswire, Inc.
Aug. 19, 2025
Axelyf Closes Seed Financing to Advance Next-Generation RNA-LNP Therapeutics
Neutral
EIN Presswire